Abstract
One of the most important inhibitory modulators of synaptic transmission in mammalian brain is adenosine. At some cholinergic terminals, adenosine is known to inhibit further release of acetyl-choline. It is unclear whether adenosine is released directly at the synapse or whether ATP is co-released with transmitter and hydro-lysed to adenosine in the synaptic cleft1–4. Methods used in the past for isolating nerve terminals have not yielded homogeneous preparations, making it impossible to determine whether sufficient ATP or adenosine is released at specific synapses for inhibition of transmitter release to occur. Immunoaffinity purification techniques5–8 have recently permitted the preparation of homogeneous populations of cholinergic nerve terminals9, which release ATP upon stimulation10. We now report that in immunoisolated cholinergic nerve terminals from the striatum synaptic ectophos-phohydrolases convert this ATP to adenosine, which inhibits further acetylcholine release, but this inhibitory effect is not seen in cortical cholinergic terminals lacking the complete ectophospho-hydrolase pathway. Therefore the differing adenosine-mediated modulation in different brain areas is controlled by the presence and activity of synaptic ectophosphohydrolases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
1. De Mey, J., Burnstock, G. & Vanhoutte, P. M. Eur. J. Pharmac. 55, 401–405 (1979). 2. Silinsky, E. M. Br. J. Pharmac. 71, 191–194 (1980). 3. Stone, T. W. / Physiol, Lond. 335, 591–608 (1983). 4. Moody, C. J. & Burnstock, G. Eur. J. Pharmac. 77, 1–9 (1982). 5. Luzio, J. P., Newby, A. C. & Hales, C. N. Biochem. J. 154, 11–21 (1976). 6. Ito, A. & Palade, G. E. /. Cell Biol. 79, 590–597 (1978). 7 Gruenberg, J. & Howell, K. E. EMBO J. 5, 3091–3101 (1986). 8. Richardson, P. J. & Luzio, J. P. Appl. Biochem. Biotechnol. 13, 133–145 (1986). 9. Richardson, P. J., Siddle, K. & Luzio, J. P. Biochem. J. 219, 647–654 (1984). 10. Richardson, P. J. & Brown, S. J. J. Neurochem. 48, 622–630 (1987). 11. Richardson, P. J., Walker, J. H., Jones, R. T. & Whittaker, V. P. /. Neurochem. 38,1605–1614 (1982). 12. Richardson, P. J. J. Neurochem. 46, 1251–1255 (1986). 13. Tashiro, T. & Stadler, H. Eur. J. Biochem. 90, 479–487 (1978). 14. Zimmermann, H. in Co-transmission (ed. Cuello, A. C.) 243–259 (Macmillan, London, 1982). 15. Pearson, J. D., Carleton, J. S. & Gordon, J. L. Biochem. J. 190, 421–429 (1980). 16. Zimmermann, H., Dowdall, M. J. & Lane, D. A. Neuroscience 4, 979–993 (1979). 17. Zimmermann, H., Grondal, E. J. M. & Kellett, F. in Cell Biology of Ectoenzymes (eds Kreutzberg, G. W., Reddington, M. & Zimmermann, H.) 35–48 (Springer, Berlin, 1986). 18. Marchi, M., Paudice, P., Caviglia, A. & Raiteri, M. Eur. J. Pharmac. 91, 63–68 (1983). 19. Pedata, F., Antonelli, T., Lambertini, L., Beani, L. & Pepeu, G. Neuropharmac. 22, 609–614 (1983). 20. Daly, J. W. J. med. Chem. 25, 197–207 (1982). 21. Stanley, K.. K., Burke, P., Pitt, P., Siddle, K. & Luzio, J. P. Expl Cell Res. 144, 39–46 (1983). 22. Stanley, K. K., Newby, A. C. & Luzio, J. P. Trends Biochem. Sci. 7, 145–147 (1982). 23. Richardson, P. J. / Neurochem. 41, 640–648 (1983). 24. Kreutzberg, G. W., Barren, K. D. & Schubert, P. Brain Res. 158, 247–257 (1978). 25. Kreutzberg, G. W., Heymann, D. & Reddington, M. in Cellular Biology of Ectoenzymes (eds Kreutzberg, G. W., Reddington, M. & Zimmermann, H.) 147–164 (Springer, Berlin, 1986). 26. Largerkrantz, H. Acta physiol. scand. Suppl. 366, 1–44 (1971). 27. Da Prada, M. & Pletscher, A. Br. J. Pharmac. 34, 591–597 (1968). 28. Harms, H. H., Wardeh, G. & Mulder, A. H. Eur. J. Pharmac. 49, 305–308 (1978). 29. Harms, H. H., Wardeh, G. & Mulder, A. H. Neuropharmacology 18, 577–580 (1979). 30. Relton, J. M., Fee, N. S., Matsas, R., Turner, A. J. & Kenny, A. J. Biochem. J. 215, 519–523 (1983). 31. Bailyes, E. M., Newby, A. C., Siddle, K. & Luzo, J. P. Biochem. J. 203, 245–251 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Richardson, P., Brown, S., Bailyes, E. et al. Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses. Nature 327, 232–234 (1987). https://doi.org/10.1038/327232a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/327232a0
This article is cited by
-
Increased ATP Release and Higher Impact of Adenosine A2A Receptors on Corticostriatal Plasticity in a Rat Model of Presymptomatic Parkinson’s Disease
Molecular Neurobiology (2023)
-
Neuroinflammation after neonatal hypoxia–ischemia is associated with alterations in the purinergic system: adenosine deaminase 1 isoenzyme is the most predominant after insult
Molecular and Cellular Biochemistry (2015)
-
Hypoxia–Ischemia Alters Nucleotide and Nucleoside Catabolism and Na+,K+-ATPase Activity in the Cerebral Cortex of Newborn Rats
Neurochemical Research (2013)
-
Immunohistological Determination of Ecto-nucleoside Triphosphate Diphosphohydrolase1 (NTPDase1) and 5′-nucleotidase in Rat Hippocampus Reveals Overlapping Distribution
Cellular and Molecular Neurobiology (2007)
-
Reduced cortical ecto-ATPase activity in rat brains during prolonged status epilepticus induced by sequential administration of lithium and pilocarpine
Molecular and Chemical Neuropathology (1997)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
